Pharmacovigilance in the Age of AI
18 August 2025 Category: Clinical TrialArtificial intelligence (AI) has become a transformative force in the increasingly digitized healthcare environment.
Artificial intelligence (AI) has become a transformative force in the increasingly digitized healthcare environment.
2025 is not just another year, a wave of innovation is crashing through biotech and bioinformatics, reshaping every stage of clinical development.
AI is no longer a distant vision in healthcare. It’s a $13.8 billion market today—and it's projected to soar past $164 billion by 2029. That’s over 1,000% growth in just a few years.
Clinical trials are drowning in data. That's not hyperbole—it's mathematics.
Global biologics sales crossed $411 billion in 2024, with top-performing therapies treating cancer, autoimmune disorders, and rare diseases.
The design and development of orphan drugs, designed for rare diseases, are uniquely challenged as limited patient populations available for clinical trials.
Clinical trials are the foundation on which medical innovation is built beginning from the development of a new treatment or therapy.
Clinical trials are more like innovations in drug therapy and perhaps even more important if they synonymously mean life-saving.
Entailing available comprehensive resources with exploration opportunities in the lives of aspiring clinical researchers who would like to indulge into education, trial data, and burgeoning India as a growing part of a global network in clinical research.
Learn how medical coding in clinical data management ensures accuracy, compliance, and streamlined data analysis in pharmaceutical research and trials.